T. Rowe Price Associates’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,308
| Closed | -$234K | – | 3006 |
|
|
2022
Q1 | $234K | Sell |
12,308
-688
| -5% | -$13.1K | ﹤0.01% | 2647 |
|
|
2021
Q4 | $231K | Buy |
12,996
+10,352
| +392% | +$184K | ﹤0.01% | 2703 |
|
|
2021
Q3 | $98K | Sell |
2,644
-367,221
| -99% | -$13.6M | ﹤0.01% | 2847 |
|
|
2021
Q2 | $22M | Buy |
369,865
+3,605
| +1% | +$214K | ﹤0.01% | 1278 |
|
|
2021
Q1 | $24.5M | Sell |
366,260
-11,124
| -3% | -$745K | ﹤0.01% | 1220 |
|
|
2020
Q4 | $22.8M | Sell |
377,384
-3,772
| -1% | -$228K | ﹤0.01% | 1193 |
|
|
2020
Q3 | $30.1M | Sell |
381,156
-2,282
| -0.6% | -$180K | ﹤0.01% | 1038 |
|
|
2020
Q2 | $24M | Sell |
383,438
-3,773
| -1% | -$236K | ﹤0.01% | 1096 |
|
|
2020
Q1 | $20.5M | Buy |
387,211
+2,420
| +0.6% | +$128K | ﹤0.01% | 1069 |
|
|
2019
Q4 | $46.6M | Buy |
384,791
+78,711
| +26% | +$9.52M | 0.01% | 937 |
|
|
2019
Q3 | $55.6M | Sell |
306,080
-133,399
| -30% | -$24.2M | 0.01% | 834 |
|
|
2019
Q2 | $57.1M | Sell |
439,479
-562
| -0.1% | -$73.1K | 0.01% | 832 |
|
|
2019
Q1 | $107M | Buy |
440,041
+9,594
| +2% | +$2.34M | 0.02% | 618 |
|
|
2018
Q4 | $82M | Sell |
430,447
-75,942
| -15% | -$14.5M | 0.01% | 655 |
|
|
2018
Q3 | $166M | Buy |
506,389
+38,303
| +8% | +$12.6M | 0.02% | 533 |
|
|
2018
Q2 | $146M | Buy |
468,086
+127,838
| +38% | +$39.9M | 0.02% | 559 |
|
|
2018
Q1 | $82.9M | Sell |
340,248
-8,380
| -2% | -$2.04M | 0.01% | 693 |
|
|
2017
Q4 | $105M | Buy |
348,628
+35,848
| +11% | +$10.8M | 0.02% | 620 |
|
|
2017
Q3 | $82.7M | Sell |
312,780
-87,723
| -22% | -$23.2M | 0.01% | 676 |
|
|
2017
Q2 | $106M | Sell |
400,503
-110,943
| -22% | -$29.2M | 0.02% | 582 |
|
|
2017
Q1 | $184M | Buy |
511,446
+38,182
| +8% | +$13.7M | 0.03% | 441 |
|
|
2016
Q4 | $137M | Buy |
473,264
+3,955
| +0.8% | +$1.14M | 0.03% | 513 |
|
|
2016
Q3 | $160M | Buy |
469,309
+35,966
| +8% | +$12.2M | 0.03% | 474 |
|
|
2016
Q2 | $184M | Buy |
433,343
+14,815
| +4% | +$6.3M | 0.04% | 434 |
|
|
2016
Q1 | $134M | Buy |
418,528
+209,649
| +100% | +$67.1M | 0.03% | 473 |
|
|
2015
Q4 | $108M | Buy |
208,879
+60,164
| +40% | +$31.2M | 0.02% | 537 |
|
|
2015
Q3 | $43.6M | Buy |
148,715
+57,186
| +62% | +$16.8M | 0.01% | 813 |
|
|
2015
Q2 | $36M | Buy |
91,529
+13,586
| +17% | +$5.34M | 0.01% | 950 |
|
|
2015
Q1 | $23.6M | Buy |
+77,943
| New | +$23.6M | ﹤0.01% | 1073 |
|